期刊文献+

滋肾清肝方及其有效成分对二肽基肽酶-4抑制作用的实验研究 被引量:1

Vitro Screening Study of Inhibitory Effect of Zishen Qinggan Formula and its Effective Ingredients on DPP-4
下载PDF
导出
摘要 目的:研究滋肾清肝方及其有效成分(2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷,1-脱氧野尻霉素和决明子苷、红镰霉素龙胆二糖苷、橙黄决明素、甲基钝叶决明素、白藜芦醇)对二肽基肽酶4(DPP-4)活性的影响,研究其发挥降糖作用的可能机制。方法:建立DPP-4抑制剂的体外筛选模型,对酶量、底物浓度、最适p H和反应时间进行优化,选择磷酸西格列汀片作为阳性对照药,通过建立的筛选模型对以上成分进行筛选,计算抑制率及IC50。结果:红镰霉素龙胆二糖苷、决明子苷、橙黄决明素、甲基钝叶决明素对DPP-4的抑制率<10%,白藜芦醇、2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷、1-脱氧野尻霉素、滋肾清肝方提取物、磷酸西格列汀对DPP-4的IC50值分别为(48.805±12.874)、(2.845±0.428)、(0.305±0.002)、(1.628±0.324)、(0.003±0.0005)mmol/L。结论:滋肾清肝方及其有效成分具有不同程度的DPP-4抑制作用,抑制DPP-4可能为其调节血糖的作用机制。 Objective:To study the inhibitory effect of Zishen Qinggan Formula and its effective ingredients(2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside,l-deoxynojirimycin,cassiaside,rubrofusarin gentiobioside,aurantio-obtusin,chryso-obtusin,resveratrol)on DPP-4,and study the possible mechanism of its hypoglycemic effect. Method:Establish vitro screening method of DPP-4 inhibitor,and the amount of enzyme,substrate concentration,the optimum p H and reaction time were optimized. And select the Sitagliptin Phosphate tablets as positive control drug. Through the screening model has been established,calculate the inhibition rate,calculate IC50. Result:The inhibition rate of DPP-4 of cassiaside,rubrofusarin gentiobioside,aurantio-obtusin,chryso-obtusin are less than 10%. IC50 value for the DPP-4 of resveratrol,2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside,l-deoxynojirimycin,extract of Zishen Qinggan formula and Sitagliptin Phosphate are(48.805±12.874) mmol/L,(2.845±0.428) mmol/L,(0.305±0.002) mmol/L,(1.628±0.324) mmol/L,(0.003±0.0005) mmol/L. Conclusions:Zishen Qinggan Formula and its effective ingredients have certain inhibitory effect on DPP-4,and Jasminoidin has the obvious inhibitory action to the DPP-4,and DPP-4 inhibitory effect may be the mechanism for regulating blood sugar.
出处 《辽宁中医药大学学报》 CAS 2016年第2期24-26,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 河北省自然科学基金资助项目(H2015209025) 河北省卫生和计划生育委员会医学科学研究重点课题(ZD20140072) 河北省高等学校科学技术研究项目(QN2015119)
关键词 滋肾清肝方 二肽基肽酶4(DPP-4) 2型糖尿病 Zishen Qinggan Formula dipeptidyl peptidase 4(DPP-4) type 2 diabetes mellitus
  • 相关文献

参考文献4

二级参考文献38

  • 1苏衍进,祝海滨.茯神汤方治疗糖尿病38例临床体会[J].陕西中医学院学报,2006,29(3):21-22. 被引量:9
  • 2马宇鹏,张中新,张延英,李继霞,李广远.中药降糖胰生胶囊对实验性糖尿病动物模型的影响[J].第四军医大学学报,2006,27(13):1160-1162. 被引量:7
  • 3刘彬,齐云,王敏,蔡润兰,宋杨.一种磷脂酶A_2抑制剂体外筛选方法的建立[J].中国药理学通报,2006,22(7):890-892. 被引量:5
  • 4Holst J J, Deacon C F. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus [ J ]. Curr Opin Pharmacol,2004,4:589 - 96.
  • 5Nagatsu T, Hino M, Fuyamada H, et at. New chromogenicsubstratesfor x-prolyldipeptidyl -aminopeptidase [ J]. Anal Biochem, 1976,74:466 - 76.
  • 6Pascual I, Lopez A, Gomez H, et al. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms[ J]. Enzyme Microb Technol ,2007 , 40 :414 - 9.
  • 7Nobuyuki Y, Tadashi N, Takashi I, et al. E3024,3-but-2-ynyl-5- methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [ 4,5-d] pyridazin-4-one tosylate, is a novel, selective and eompetitivedipeptidylpeptidase- Ⅳ inhibitor [ J ]. Eur J Pharmacol,2006,548 : 181 - 7.
  • 8Inger B,Jurgen J, Xin C, et al. IV catalyzed peptide truncation Inhibition of dipeptidyl-peptidase by Vildagliptin ( ( 2S ) - / [ ( 3- hydroxyadamantan-1-yl) amino { acetyl } -pyrrolidine-2-carbonitrile ] [ J ]. Biochemical pharmacology, 2005,70 : 134 - 43.
  • 9Lan Zhu, Tamvakopoulos C,Dan Xie, et al. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides[J]. J Bio Chem, 2003, 278(25):22418- 22423.
  • 10Mentlein R. Dipeptidy-1 peptidase IV(CD26) role in the inactivation of regulatory peptides[J]. Regul Pept,1999, 85:9-24.

共引文献24

同被引文献15

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部